SCHEMBL10089943

SCHEMBL10089943

Cc1ccc(Cl)c(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1NC(=O)c1cc(Cn2nnc(C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.37
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
PTGER4 P35408 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 3/20 0.34
GAA P10253 1/20 0.34
WDR5 P61964 1/20 0.34
CYP3A4 P08684 1/20 0.33
ADRB2 P07550 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15905608 0.94 GLS (0.38) RIPK1WDR5MAPK1
SCHEMBL10090047 0.93 DHODH (0.37)
SCHEMBL15905605 0.89 HSD17B13 (0.40) RIPK1MAPK1EPHX2
SCHEMBL10089898 0.89 PDE2A (0.35) ALDH1A1HPGDCYP2C9CYP2C19CYP1A2
SCHEMBL10089984 0.89 MMP13 (0.38) HPGDWDR5
SCHEMBL10089836 0.89 PDE2A (0.35) RIPK1ALDH1A1HPGDCYP2C9CYP2C19
SCHEMBL10090021 0.89 GLS (0.36) RIPK1WDR5MAPK1
SCHEMBL10089940 0.88 TP53 (0.35) ALDH1A1CYP2C19CYP1A2SMN1; SMN2GAA
SCHEMBL10090033 0.88 PDE2A (0.35) RIPK1ALDH1A1HPGDCYP2C9CYP2C19
SCHEMBL10090035 0.87 SLC2A1 (0.36) ALDH1A1HPGDCYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 RIPK1 4585/4885ALDH1A1 989/4885HPGD 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.